此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Clinical Evaluation of Nano-Hydroxyapatite as an Adjunctive to Minimally Invasive Non-Surgical Technique in the Treatment of Deep Intra-bony Defects (MINST)

2026年5月27日 更新者:Salah Eddin Sheet、Cairo University

Clinical Evaluation of Nano-Hydroxyapatite as an Adjunctive to Minimally Invasive Non-Surgical Technique in the Treatment of Deep Intra-bony Defects: A Randomized Controlled Clinical Trial

This randomized controlled clinical trial aims to evaluate the effectiveness of using nano-hydroxyapatite (nHA) gel alongside a minimally invasive non-surgical technique (MINST) to treat deep intra-bony defects in patients with Stage III periodontitis. While MINST is an effective method for cleaning deep periodontal pockets without the need for traditional surgery, the addition of nHA may further enhance soft tissue healing, improve cellular interaction, and promote bone regeneration. Participants in the study will be randomly assigned to one of two groups. The test group will receive the MINST procedure combined with the application of nHA gel directly into the periodontal pocket, while the control group will receive the MINST procedure alone. The primary goal of the study is to measure the decrease in probing pocket depth over a 6-month follow-up period to determine if the adjunctive use of nHA provides superior clinical outcomes compared to non-surgical treatment alone.

研究概览

研究类型

介入性

注册 (实际的)

28

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Cairo、埃及、11511
        • Oral Medicine and Periodontology department, Faculty of Dentistry - Cairo University.

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Systemically healthy adults aged 18-65 years.
  • No history of systemic diseases affecting periodontal status or bone metabolism (e.g., uncontrolled diabetes, osteoporosis).
  • Diagnosed with Stage III periodontitis according to the 2018 classification of periodontal diseases (with interdental CAL ≥5 mm, probing depth ≥6 mm).
  • Presence of at least one deep intra-bony defect (≥3 mm defect depth) in a single-rooted or multi-rooted tooth.
  • Willingness to participate and sign informed consent.

Exclusion Criteria:

  • Immunocompromised patients, uncontrolled diabetics (HbA1c ≥ 7.0%), or individuals with autoimmune disorders.
  • History of malignancy or chemotherapy/radiation in the past year.
  • Use of bisphosphonates, corticosteroids, immunosuppressive antibiotics or anti-inflammatory agents within 6 months before periodontal therapy.
  • Smokers (≥ 10 cigarettes per day).
  • Pregnant or breastfeeding women, confirmed via medical history and/or test.
  • Receipt of periodontal surgery or nonsurgical treatment within the last 6 months.
  • Teeth with peri-apical pathology, acute abscess, or grade III mobility.
  • Multi-rooted teeth with class II and class III furcation defects.
  • Third molars.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
有源比较器:MINST alone
Participants receive the minimally invasive non-surgical technique (MINST) alone without adjunctive treatment
Subgingival debridement using thin ultrasonic tips and Gracey mini-curettes under magnification, deliberately avoiding subgingival rinsing to support blood clot stabilization
实验性的:MINST + nano-hydroxyapatite
Participants receive MINST combined with the adjunctive application of nano-hydroxyapatite gel
Subgingival debridement using thin ultrasonic tips and Gracey mini-curettes under magnification, deliberately avoiding subgingival rinsing to support blood clot stabilization
A single dose of nano-hydroxyapatite (nHA) gel applied subgingivally directly into the periodontal pocket associated with the intrabony defect immediately following debridement

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Probing Pocket Depth (PPD)
大体时间:6 months
Measured in millimeters (mm) using a manual periodontal probe (UNC-15)
6 months

次要结果测量

结果测量
措施说明
大体时间
Clinical Attachment Level (CAL)
大体时间:1, 3, and 6 months post-treatment.
Measured in millimeters (mm) using a manual periodontal probe (UNC-15).
1, 3, and 6 months post-treatment.
Gingival Recession (GR)
大体时间:1, 3, and 6 months post-treatment.
Measured in millimeters (mm) using a manual periodontal probe (UNC-15).
1, 3, and 6 months post-treatment.
Radiographic Defect Angle (RDA)
大体时间:1, 3, and 6 months post-treatment.
Measured in degrees (°) utilizing standardized periapical radiographs and measurement software.
1, 3, and 6 months post-treatment.
Patient Satisfaction
大体时间:1, 3, and 6 months post-treatment.
Assessed via a structured questionnaire utilizing a Likert scale. The scale ranges from 1 to 5, where 1 indicates "Very Dissatisfied" and 5 indicates "Very Satisfied," meaning higher scores represent a better outcome.
1, 3, and 6 months post-treatment.
Full-Mouth Plaque Score (FMPS)
大体时间:1, 3, and 6 months post-treatment.
Assessed as a percentage (%) using the Visible Plaque Index (O'Leary et al.). The index ranges from a minimum of 0% to a maximum of 100%. Higher percentages indicate a greater presence of plaque, representing a worse clinical outcome.
1, 3, and 6 months post-treatment.
Full-Mouth Bleeding Score (FMBS)
大体时间:1, 3, and 6 months post-treatment.
Assessed as a percentage (%) using the Gingival Bleeding Index (Ainamo & Bay). The index ranges from a minimum of 0% to a maximum of 100%. Higher percentages indicate more widespread gingival bleeding, representing a worse clinical outcome.
1, 3, and 6 months post-treatment.
Cost Effectiveness based on Clinical Attachment Level (CAL)
大体时间:6 months post-treatment.
Evaluated using the cost-effectiveness ratio (CER) and incremental cost-effectiveness ratio (ICER), based on the cost in USD per millimeter (mm) of CAL improvement.
6 months post-treatment.
Cost Effectiveness based on Probing Pocket Depth (PPD)
大体时间:6 months post-treatment.
Evaluated using the cost-effectiveness ratio (CER) and incremental cost-effectiveness ratio (ICER), based on the cost in USD per millimeter (mm) of PPD improvement.
6 months post-treatment.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年7月1日

初级完成 (估计的)

2026年8月1日

研究完成 (估计的)

2026年8月28日

研究注册日期

首次提交

2026年5月20日

首先提交符合 QC 标准的

2026年5月20日

首次发布 (实际的)

2026年5月27日

研究记录更新

最后更新发布 (实际的)

2026年5月29日

上次提交的符合 QC 标准的更新

2026年5月27日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅